Have a personal or library account? Click to login
Hypertension Cascade Across Three Healthcare Systems and in Relation to the Level of Implementation of the Integrated Care Package Cover

Hypertension Cascade Across Three Healthcare Systems and in Relation to the Level of Implementation of the Integrated Care Package

Open Access
|Aug 2025

References

  1. 1Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nature Reviews Nephrology. 2020;16(4):223237. DOI: 10.1038/s41581-019-0244-2
  2. 2Stanaway JD, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):19231994.
  3. 3Marra C, et al. Cost-effectiveness of pharmacist care for managing hypertension in Canada. Canadian Pharmacists Journal. 2017;150(3):184197. DOI: 10.1177/1715163517701109
  4. 4Dugani S, Gaziano TA. 25 by 25: Achieving Global Reduction in Cardiovascular Mortality. Current Cardiology Reports. 2016;18(1). DOI: 10.1007/s11886-015-0679-4
  5. 5Mills KT, et al. Global Disparities of Hypertension Prevalence and Control A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016;134(6):441450. DOI: 10.1161/CIRCULATIONAHA.115.018912
  6. 6Santosa A, Zhang Y, Weinehall L, et al. Gender differences and determinants of prevalence, awareness, treatment and control of hypertension among adults in China and Sweden. BMC Public Health. 2020;1763. DOI: 10.1186/s12889-020-09862-4
  7. 7Connelly PJ, Currie G, Delles C. Sex Differences in the Prevalence, Outcomes and Management of Hypertension. Curr Hypertens Rep. 2022;24:185192. DOI: 10.1007/s11906-022-01183-8
  8. 8Mohanty SK, et al. Awareness, treatment, and control of hypertension in adults aged 45 years and over and their spouses in India: A nationally representative cross-sectional study. Plos Medicine. 2021;18(8):e1003740. DOI: 10.1371/journal.pmed.1003740
  9. 9Chow CK, et al. Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries. Jama-Journal of the American Medical Association. 2013;310(9):959968. DOI: 10.1001/jama.2013.184182
  10. 10Peters MA, et al. Evidence for an expanded hypertension care cascade in low- and middle-income countries: a scoping review. Bmc Health Services Research. 2022;22(827). DOI: 10.1186/s12913-022-08190-0
  11. 11Zhang YT, et al. Effects of integrated chronic care models on hypertension outcomes and spending: a multi-town clustered randomized trial in China. Bmc Public Health. 2017;17(244). DOI: 10.1186/s12889-017-4141-y
  12. 12Glynn LG, et al. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database of Systematic Reviews. 2010;17(3):CD005182. DOI: 10.1002/14651858.CD005182.pub4
  13. 13Jaffe MG, et al. Improved Blood Pressure Control Associated With a Large-Scale Hypertension Program. Jama-Journal of the American Medical Association. 2013;310(7):699705. DOI: 10.1001/jama.2013.108769
  14. 14Raak A, et al. Integrated care in Europe. Description and comparison of integrated care in six EU countries. Maarssen: Elsevier Gezondheidzorg. 208; 2003.
  15. 15WHO. Implementation Tools: Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low-Resource Settings. Geneva, Switzerland: WHO; 2013.
  16. 16Demaio AR, et al. Primary Health Care: a strategic framework for the prevention and control of chronic non-communicable disease. Global Health Action. 2014;7(24504). DOI: 10.3402/gha.v7.24504
  17. 17Stojnić N, et al. Evaluation of the Implementation of Integrated Primary Care for Patients with Type 2 Diabetes and Hypertension in Belgium, Cambodia, and Slovenia. International Journal of Integrated Care. 2024;24(2):27,112. DOI: 10.5334/ijic.7664
  18. 18Egan BM, Zhao YM, Axon RN. US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988–2008. Jama-Journal of the American Medical Association. 2010;303(20):20432050. DOI: 10.1001/jama.2010.650
  19. 19Wozniak G, et al. Hypertension Control Cascade: A Framework to Improve Hypertension Awareness, Treatment, and Control. J Clin Hypertens (Greenwich). 2016;18(3):232239. DOI: 10.1111/jch.12654
  20. 20Menendez E, et al. Prevalence, Diagnosis, Treatment, and Control of Hypertension in Spain. Results of the Di@bet.es Study. Revista Espanola De Cardiologia. 2016;69(6):572578. DOI: 10.1016/j.rec.2015.11.034
  21. 21Ikeda N, et al. Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. Bulletin of the World Health Organization. 2014;92(1):1019. DOI: 10.2471/BLT.13.121954
  22. 22van Olmen J, et al. Scale-up integrated care for diabetes and hypertension in Cambodia, Slovenia and Belgium (SCUBY): a study design for a quasi-experimental multiple case study. Global Health Action. 2020;13(1):1824382. DOI: 10.1080/16549716.2020.1824382
  23. 23Reibling N, Ariaans M, Wendt C. Worlds of Healthcare: A Healthcare System Typology of OECD Countries. Health Policy. 2019;123(7):611620. DOI: 10.1016/j.healthpol.2019.05.001
  24. 24Kringos D, et al. The strength of primary care in Europe: an international comparative study. British Journal of General Practice. 2013;63(616):E742E750. DOI: 10.3399/bjgp13X674422
  25. 25Lember M, Cartier T, Bourgueil Y. Chapter 2: Structure and organization of primary care. In: Kringos DS, et al. Editors. Building primary care in a changing Europe. Observatory Study Series WHO; 2015.
  26. 26THE THIRD HEALTH STRATEGIC PLAN 2016–2020 (HSP3) “Quality, Effective and Equitable Health Services”. 2016, Department of Planning and Health Information, Ministry of Health.: Cambodia.
  27. 27Chham S, et al. The cascade of hypertension care in Cambodia: evidence from a cross-sectional population-based survey. Bmc Health Services Research. 2022;22(1). DOI: 10.1186/s12913-022-08232-7
  28. 28Bos P, Wouters E, Danhieux K. et al. Unravelling the Belgian cascade of hypertension care and its determinants: insights from a cross-sectional analysis. BMC Public Health. 2024;24:1559. DOI: 10.1186/s12889-024-19010-x
  29. 29Te V, Long S, Damme WV, Ir P, Wouters E, van Olmen J. An in-depth Analysis of the Degree of Implementation of Integrated Care for Diabetes in Primary Health Care in Cambodia. International Journal of Integrated Care. 2024;24(4):11,110. DOI: 10.5334/ijic.7602
  30. 30Klemenc-Ketis Z, et al. Implementation of integrated primary care for patients with diabetes and hypertension: a case from Slovenia. International Journal of Integrated Care. 2021;21(3). DOI: 10.5334/ijic.5637
  31. 31Danhieux K, Buffel V, Remmen R, et al. Scale-up of a chronic care model-based programme for type 2 diabetes in Belgium: a mixed-methods study. BMC Health Serv Res. 2023;23:141. DOI: 10.1186/s12913-023-09115-1
  32. 32Creswell JW, Creswell JD. Mixed methods procedures. In: Research design: Qualitative, quantitative, and mixed methods approaches (5th ed.). 2018; pp. 213246. Los Angeles, CA: SAGE Publications, Inc.
  33. 33Zhou B, et al. Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. The Lancet. 2019;394(10199):639651. DOI: 10.1016/S0140-6736(19)31145-6
  34. 34de Cort P, et al. Aanbeveling voor goede medische praktijkvoering: hypertensie (herziening). Huisarts nu: maandblad van de Wetenschappelijke Vereniging van Vlaamse Huisartsen. Brussel. 2009;38(9):340361.
  35. 35Blinc A, et al. 2018. Ljubljana: Združenje za arterijsko hipertenzijo, Slovensko zdravniško društvo; 2019. https://hipertenzija.org/wp-content/uploads/2019/12/Smernice-za-obravnavo-hipertenzije-2018.pdf
  36. 36Medicine DoP. National standard operating procedure for diabetes and hypertension management in primary care 2019. Cambodia: Ministry of Health; 2019.
  37. 37Demarest S, Berete F, Charafeddine S, Van der Heyden J. Gezondheidsenquête. 2018: Methodologie. Brussel, België: Sciensano. Rapportnummer: D/2019/14.440/34. Accessible: www.gezondheidsenquete.be
  38. 38Nguyen D, et al. The Belgian health examination survey: objectives, design and methods. Archives of Public Health. 2020;78(1). DOI: 10.1186/s13690-020-00428-9
  39. 39Te V, et al. Generation of cascades of care for diabetes and hypertension care continuum in Cambodia: protocol for a population-based survey protocol. JMIR Res Protoc. 2022;11(9):e36747. DOI: 10.2196/36747
  40. 40Bowskill R, Clatworthy J, Parham R, Rank T, Horne R. Patients’ perceptions of information received about medication prescribed for bipolar disorder: implications for informed choice. J Affect Disord. 2007;100(1–3):253257. DOI: 10.1016/j.jad.2006.10.018
  41. 41Mårdby A-C, Åkerlind I, Jörgensen T. Beliefs about medicines and self-reported adherence among pharmacy clients. Patient Educ Couns. 2007;69(1):158164. DOI: 10.1016/j.pec.2007.08.011
  42. 42World Population Prospects: The 2010 Revision, Volume I: Comprehensive Tables. United Nations, Department of Economic and Social Affairs, Population Division; 2011.
  43. 43Klemenc-Ketiš Z, Švab I, Poplas Susič A. Implementing Quality Indicators for Diabetes and Hypertension in Family Medicine in Slovenia. Zdr Varst. 2017;56(4):211219. DOI: 10.1515/sjph-2017-0029
  44. 44Bocquet V, Barré J, Couffignal S, et al. Study design and characteristics of the Luxembourg European Health Examination Survey (EHES-LUX). BMC Public Health. 2018;18(1169). DOI: 10.1186/s12889-018-6087-0
  45. 45De Backer T, Van Nieuwenhuyse B, De Bacquer D. Antihypertensive treatment in a general uncontrolled hypertensive population in Belgium and Luxembourg in primary care: Therapeutic inertia and treatment simplification. The SIMPLIFY study. PLoS One. 2021;16(4):e0248471. DOI: 10.1371/journal.pone.0248471
  46. 46Gerkens S, Merkur S. Belgium: health system review. Health systems in transition. 2020;1237.
  47. 47Karakaya G, Umbach I. Analyse van de behandelingen met antihypertensiva [Analysis of antihypertensive treatments]. Brussel, België: Onafhankelijke Ziekenfondsen; 2023.
  48. 48Geldsetzer P, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1.1 million adults. Lancet. 2019;394(10199):652662. DOI: 10.1016/S0140-6736(19)30955-9
  49. 49Attaei MW, et al. Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet Public Health. 2017;2(9):E411E419.
  50. 50Viswanathan M, et al. Interventions to Improve Adherence to Self-administered Medications for Chronic Diseases in the United States A Systematic Review. Annals of Internal Medicine. 2012;157(11):785795. DOI: 10.7326/0003-4819-157-11-201212040-00538
  51. 51Chham S, et al. Scaling-up integrated type-2 diabetes and hypertension care in Cambodia: what are the barriers to health system performance? Frontiers in Public Health. 2023;11(1136520). DOI: 10.3389/fpubh.2023.1136520
  52. 52Khatib R, et al. Patient and Healthcare Provider Barriers to Hypertension Awareness, Treatment and Follow Up: A Systematic Review and Meta-Analysis of Qualitative and Quantitative Studies. Plos One. 2014;9(1). DOI: 10.1371/journal.pone.0084238
  53. 53Woodward A, et al. Self-management of multiple long-term conditions: A systematic review of the barriers and facilitators amongst people experiencing socioeconomic deprivation. PLoS One. 2023;12(2):e0282036. DOI: 10.1371/journal.pone.0282036
  54. 54Stephen C, et al. Nurse-led interventions to manage hypertension in general practice: A systematic review and meta-analysis. J Adv Nurs. 2022;78(5):12811293. DOI: 10.1111/jan.15159
  55. 55Virtič T, et al. Peer Support as Part of Scaling-Up Integrated Care in Patients with Type 2 Diabetes and Arterial Hypertension at the Primary Healthcare Level: A Study Protocol. Zdr Varst. 2023;62(2):93100. DOI: 10.2478/sjph-2023-0013
  56. 56Irazola VE, et al. Hypertension Prevalence, Awareness, Treatment, and Control in Selected LMIC Communities: Results From the NHLBI/UHG Network of Centers of Excellence for Chronic Diseases. Glob Heart. 2016;11(1):4759. DOI: 10.1016/j.gheart.2015.12.008
  57. 57Atwood KM, et al. Comparison of Diagnosed, Self-Reported, and Physically-Measured Hypertension in Canada. Canadian Journal of Cardiology. 2013;29(5):606612. DOI: 10.1016/j.cjca.2012.11.019
  58. 58Leong A, et al. Systematic Review and Meta-Analysis of Validation Studies on a Diabetes Case Definition from Health Administrative Records. Plos One. 2013;8(10). DOI: 10.1371/journal.pone.0075256
  59. 59Bonomi AE, et al. Assessment of Chronic Illness Care (ACIC): A practical tool to measure quality improvement. Health Services Research. 2002;37(3):791820. DOI: 10.1111/1475-6773.00049
DOI: https://doi.org/10.5334/ijic.8921 | Journal eISSN: 1568-4156
Language: English
Submitted on: Jun 18, 2024
Accepted on: Aug 7, 2025
Published on: Aug 22, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Veerle Buffel, Philippe Bos, Savina Chham, Srean Chimm, Katrien Danhieux, Grace Marie Ku, Josefien Van Olmen, Crt Zavrnik, Zalika Klemenc-Ketis, Edwin Wouters, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.